Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
28.01.25
/
50%
€4.54
Target price
28.01.26
€8.63
Performance (%)
-61.89%
End price
29.01.26
€1.73
Summary
This prediction ended on 29.01.26 with a price of €1.73. Massive losses of -61.89% were the result for the BUY prediction by Guggenheim. Guggenheim has a follow-up prediction for Eledon Pharmaceuticals Inc. where he still thinks Eledon Pharmaceuticals Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eledon Pharmaceuticals Inc. | 6.790% | 6.790% | -59.767% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
In the thread Trading Eledon Pharmaceuticals Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.34
18.11.25
18.11.25
€6.90
18.11.26
18.11.26
26.12%
19.02.26
19.02.26
